Key facts
- ARTAN Bio completed a $200,000 seed funding round.
- The funds will advance ARTAN Bio's engineered suppressor platform.
- The platform targets mutation-specific codon suppression for longevity.
- ARTAN Bio is a longevity biotechnology company based in St. Petersburg, Florida.
ARTAN Bio, a biotechnology firm focused on longevity, has successfully raised $200,000 in seed funding. This capital infusion is earmarked for the preclinical development of the company's unique engineered suppressor platform. This technology is designed to tackle challenges related to mutation-specific codon suppression, with the ultimate goal of advancing longevity science. The company is based in St. Petersburg, Florida.